Halozyme Therapeutics, Inc. (HALO)
68.36
+0.20
(+0.29%)
USD |
NASDAQ |
Dec 23, 16:00
68.38
+0.02
(+0.03%)
After-Hours: 20:00
Halozyme Therapeutics Price: 68.36 for Dec. 23, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 205.78 |
| Merck & Co., Inc. | 105.04 |
| ANI Pharmaceuticals, Inc. | 80.73 |
| Bristol Myers Squibb Co. | 54.28 |
| AIM ImmunoTech, Inc. | 1.30 |
Price Related Metrics
| PE Ratio | 14.37 |
| PS Ratio | 6.904 |
| PEG Ratio | 0.2502 |
| Price to Book Value | 15.95 |
| Price to Free Cash Flow | 14.24 |
| Earnings Yield | 6.96% |
| Market Cap | 8.039B |
| PEGY Ratio | 0.2502 |
| Operating PE Ratio | 11.64 |
| Normalized PE Ratio | 14.37 |